Seattle Genetics to Host Conference Call and Webcast Discussion of First Quarter 2012 Financial Results on May 8, 2012
BOTHELL, Wash.--(BUSINESS WIRE)-- Seattle Genetics, Inc. (SGEN) announced today that it will report its first quarter 2012 financial results on Tuesday, May 8, 2012, after the close of financial markets. Following the announcement, company management will host a conference call and webcast discussion of the results and provide a general corporate update. Access to the event can be obtained as follows:
LIVE access on Tuesday, May 8, 2012
1:30 p.m. Pacific Time (PT) / 4:30 p.m. Eastern Time (ET)
- Telephone 877-941-6009 (domestic) or 480-629-9866 (international); conference ID 4532828
- Webcast available at http://www.seattlegenetics.com in the Investors and News section
- Telephone replay will be available beginning at approximately 3:30 p.m. PT on Tuesday, May 8, 2012, through 5:00 p.m. PT on Thursday, May 10, 2012, by calling 800-406-7325 (domestic) or 303-590-3030 (international); conference ID 4532828
- Webcast replay will be available on the Seattle Genetics website at http://www.seattlegenetics.com in the Investors and News section
About Seattle Genetics
Seattle Genetics is a biotechnology company focused on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer. The U.S. Food and Drug Administration granted accelerated approval of ADCETRIS in August 2011 for two indications. ADCETRIS is being developed in collaboration with Millennium: The Takeda Oncology Company. In addition, Seattle Genetics has three other clinical-stage ADC programs: SGN-75, ASG-5ME and ASG-22ME. Seattle Genetics has collaborations for its ADC technology with a number of leading biotechnology and pharmaceutical companies, including Abbott, Bayer, Celldex Therapeutics, Daiichi Sankyo, Genentech, GlaxoSmithKline, Millennium, Pfizer and Progenics, as well as ADC co-development agreements with Agensys, an affiliate of Astellas, and Genmab. More information can be found at www.seattlegenetics.com.
Seattle Genetics, Inc.
Peggy Pinkston, 425-527-4160
Source: Seattle Genetics, Inc.Copyright Business Wire 2012